Alterity Therapeutics Seeks ASX Quotation
Company Announcements

Alterity Therapeutics Seeks ASX Quotation

Alterity Therapeutics Ltd. (AU:ATH) has released an update.

Alterity Therapeutics Limited has announced the application for quotation of a total of 75,220,800 ordinary fully paid securities on the ASX under the code ATH, with the issue date set for July 18, 2024. This move is detailed in their latest Appendix 2A submission, marking a significant step for the company in the financial market.

For further insights into AU:ATH stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskAlterity Therapeutics Unveils Annual Financial Results
TheFlyAlterity Therapeutics reports cash balance of A$12.6M as of June 30
GlobeNewswireAppendix 4C – Q4 FY24 Quarterly Cash Flow Report
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App